Loading
Rovi
Rovi is a Madrid pharmaceutical group known for low-molecular-weight heparins and long-acting injectables; its bemiparin trials in cancer-associated thrombosis are why it appears among phase 3 cancer sponsors.
Also called: Laboratorios Farmacéuticos RoviRovi Pharmaceuticals LaboratoriesLaboratorios Rovi
Overview
Laboratorios Farmacéuticos Rovi, founded in 1946 in Madrid and listed on the Spanish stock exchange, makes the low-molecular-weight heparin bemiparin, contract-manufactures injectables and develops long-acting formulations. Its phase 3 trials of bemiparin for preventing and treating venous thromboembolism in cancer patients are registered on ClinicalTrials.gov under Rovi as lead sponsor.
Connected
4Similar pages
- CompanyPregLem
- CompanyAgennix
- CompanyLisata Therapeutics
- CompanyImmunitor
- CompanyEmergent BioSolutions
- CompanyHarbour BioMed
- CompanyVion Pharmaceuticals
- CompanyCyclacel Pharmaceuticals
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
ClinicalTrials.gov · 1
rovi.es · 1
wikidata.org · 1
A source that has moved or gone is reported by the weekly link check. /audit/